FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010481034> ?p ?o ?g. }

• W2010481034 endingPage "1672" @default.
• W2010481034 startingPage "1664" @default.
• W2010481034 abstract "The tumor suppressor protein, p53, is central to the pathways that monitor the stress, DNA damage repair, cell cycle, aging, and cancer. Highly complex p53 networks involving its upstream sensors and regulators, downstream effectors and regulatory feedback loops have been identified. CARF (Collaborator of ARF) was shown to enhance ARF-dependent and -independent wild-type p53 function. Here we report that (i) CARF overexpression causes premature senescence of human fibroblasts, (ii) it is vital for replicative and stress-induced senescence, and (iii) the lack of CARF function causes aneuploidy and apoptosis. We provide evidence that CARF plays a dual role in regulating p53-mediated senescence and apoptosis, the two major tumor suppressor mechanisms. The tumor suppressor protein, p53, is central to the pathways that monitor the stress, DNA damage repair, cell cycle, aging, and cancer. Highly complex p53 networks involving its upstream sensors and regulators, downstream effectors and regulatory feedback loops have been identified. CARF (Collaborator of ARF) was shown to enhance ARF-dependent and -independent wild-type p53 function. Here we report that (i) CARF overexpression causes premature senescence of human fibroblasts, (ii) it is vital for replicative and stress-induced senescence, and (iii) the lack of CARF function causes aneuploidy and apoptosis. We provide evidence that CARF plays a dual role in regulating p53-mediated senescence and apoptosis, the two major tumor suppressor mechanisms. The tumor suppressor protein, p53, is the most frequently inactivated protein in human cancers that symbolizes deregulation of genomic stability, cell cycle, senescence, and stress damage-repair response of cells (1Bartkova J. Rezaei N. Liontos M. Karakaidos P. Kletsas D. Issaeva N. Vassiliou L.V. Kolettas E. Niforou K. Zoumpourlis V.C. Takaoka M. Nakagawa H. Tort F. Fugger K. Johansson F. Sehested M. Andersen C.L. Dyrskjot L. Ørntoft T. Lukas J. Kittas C. Helleday T. Halazonetis T.D. Bartek J. Gorgoulis V.G. Nature. 2006; 444: 633-637Crossref PubMed Scopus (1510) Google Scholar, 2Bartek J. Bartkova J. Lukas J. Oncogene. 2007; 26: 7773-7779Crossref PubMed Scopus (435) Google Scholar, 3Yaswen P. Campisi J. Cell. 2007; 128: 233-234Abstract Full Text Full Text PDF PubMed Scopus (110) Google Scholar, 4Rodier F. Campisi J. Bhaumik D. Nucleic Acids Res. 2007; 35: 7475-7484Crossref PubMed Scopus (296) Google Scholar, 5Campisi J. Aging Cell. 2007; 6: 261-263Crossref PubMed Scopus (37) Google Scholar). p53 signaling has been established as a complex network comprised of (i) upstream components consisting of stress signals and sensor proteins including kinases, transferases, methyalses, ligases, and others that regulate its activity either by post-translational modifications or by subcellular localization, (ii) core regulators including an upstream positive regulator (alternative reading frame, ARF) 4The abbreviations used are: ARF, alternative reading frame; HDM2, human double minute-2; CARF, Collaborator of ARF; siRNA, small interference RNA; PBS, phosphate-buffered saline; GFP, green fluorescent protein; TUNEL, terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling; SIPS, stress-induced premature senescence; BrdU, bromodeoxyuridine; Wt, wild type. protein that blocks its downstream effector and antagonist human double minute-2 (HDM2) protein, and (iii) the downstream effectors that determine the fate of cells by instigation of growth arrest, senescence, or apoptosis, the three potent tumor suppressor mechanisms. In addition to the fact that the initiation of DNA damage-induced senescence and establishment of growth arrest require p53 activation (4Rodier F. Campisi J. Bhaumik D. Nucleic Acids Res. 2007; 35: 7475-7484Crossref PubMed Scopus (296) Google Scholar), a large number of studies have shown that the persistent inactivation of p53 is required for tumor maintenance. Cancer cells undergo either growth arrest or apoptosis with restoration of wild-type p53 function in vitro and in vivo (6Ventura A. Kirsch D.G. McLaughlin M.E. Tuveson D.A. Grimm J. Lintault L. Newman J. Reczek E.E. Weissleder R. Jacks T. Nature. 2007; 445: 661-665Crossref PubMed Scopus (1413) Google Scholar, 7Xue W. Zender L. Miething C. Dickins R.A. Hernando E. Krizhanovsky V. Cordon-Cardo C. Lowe S.W. Nature. 2007; 445: 656-660Crossref PubMed Scopus (1863) Google Scholar, 8Martins C.P. Brown-Swigart L. Evan G.I. Cell. 2006; 127: 1323-1334Abstract Full Text Full Text PDF PubMed Scopus (509) Google Scholar). These studies have prioritized further understanding of p53 signaling and regulation that would have major impact in cancer drug development. It is yet to be resolved how functional restoration of p53 culminates to growth arrest/senescence in some cells and apoptosis in others. Is it driven by the level of p53 expression, modulating partner proteins or its upstream regulators? Among the large number of p53-binding proteins that influence its activities, ARF and HDM2 have been demonstrated as its major regulators. HDM2 (an E3 ubiquitin ligase) is transcriptionally activated by p53 and acts to degrade p53 in turn; thus, executing a negative feedback loop on p53 activity. ARF has been shown to bind and inhibit HDM2 activity resulting in the activation of p53 pathway (9Zhang Y. Xiong Y. Yarbrough W.G. Cell. 1998; 92: 725-734Abstract Full Text Full Text PDF PubMed Scopus (1411) Google Scholar). CARF (Collaborator of ARF) protein was initially cloned as an ARF-binding protein by yeast two-hybrid screening and was shown to activate ARF-dependent and -independent p53 functions (10Hasan M.K. Yaguchi T. Minoda Y. Hirano T. Taira K. Wadhwa R. Kaul S.C. Biochem. J. 2004; 380: 605-610Crossref PubMed Scopus (35) Google Scholar, 11Hasan M.K. Yaguchi T. Harada J.I. Hirano T. Wadhwa R. Kaul S.C. Int. J. Oncol. 2008; 32: 663-671PubMed Google Scholar, 12Kaul S.C. Hasan K. Wadhwa R. Ann. N. Y. Acad. Sci. 2006; 1067: 217-219Crossref PubMed Scopus (8) Google Scholar, 13Wadhwa R. Sugihara T. Hasan M.K. Duncan E.L. Taira K. Kaul S.C. Exp. Gerontol. 2003; 38: 245-252Crossref PubMed Scopus (16) Google Scholar). CARF interacts not only with ARF but also with p53 and HDM2, and thereby executes a new feedback loop in p53 pathway: CARF activates p53 → activates HDM2 → degrades CARF and p53. CARF also regulates HDM2 by its transcriptional repressor function (10Hasan M.K. Yaguchi T. Minoda Y. Hirano T. Taira K. Wadhwa R. Kaul S.C. Biochem. J. 2004; 380: 605-610Crossref PubMed Scopus (35) Google Scholar, 11Hasan M.K. Yaguchi T. Harada J.I. Hirano T. Wadhwa R. Kaul S.C. Int. J. Oncol. 2008; 32: 663-671PubMed Google Scholar, 12Kaul S.C. Hasan K. Wadhwa R. Ann. N. Y. Acad. Sci. 2006; 1067: 217-219Crossref PubMed Scopus (8) Google Scholar, 14Cheung C.T. Hasan M.K. Widodo N. Kaul S.C. Wadhwa R. Mech. Ageing Dev. 2008; (in press)PubMed Google Scholar). In the present study, we demonstrate that CARF is vital for senescence of normal human fibroblasts. Whereas the overexpression of CARF induces premature senescence, its suppression leads to genomic instability and apoptosis. Construction of Retroviral Expression Vectors—For construction of retrovirus-driven expression of CARF-Myc, pCX4neo (provided by Dr. Tsuyoshi Akagi, Osaka, Japan) was used. cDNA-encoding Myc-tagged CARF protein was cloned into the BamHI and EcoRI sites of the vector. For pCX4neo-CARF-GFP construction, CARF cDNA was first cloned into the EcoRI and BamHI site of the pEGFP-N1 vector (Clontech), and then CARF-GFP fragment was isolated by EcoRI-NotI digestion and subcloned into the EcoRI-NotI site of the pCX4neo vector. Cell Culture—Cells (HeLa, U2OS, TIG-1, MRC5 and the multicolor MDA-MB-435 cells stably expressing GFP-Aurora A kinase, DsRed-Dimportin α2, and CFP-histone H3 as markers for the centrosomes/mitotic spindles, nuclear membrane, and the nucleus/chromosomes, respectively) were grown at 37 °C in a 5% CO2 incubator in low glucose Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 50 units/ml penicillin, and 5 mg/ml streptomycin. U2OS cells with Zn-inducible CARF expression were prepared as described earlier (11Hasan M.K. Yaguchi T. Harada J.I. Hirano T. Wadhwa R. Kaul S.C. Int. J. Oncol. 2008; 32: 663-671PubMed Google Scholar). p53-/- and MDM2-/- fibroblasts were a kind gift from Dr. Lozano (15Barboza J.A. Iwakuma T. Terzian T. El-Naggar A.K. Lozano G. Mol. Cancer Res. 2008; 6: 947-954Crossref PubMed Scopus (75) Google Scholar) For the production of retroviruses, Plat-E, an ecotropic murine leukemia virus (MuLV)-packaging cell line, was transfected with the pVPack-GP (expression gal and pol) and pVPack VSVG (expressing env) vectors (Stratagene, CA), with CARF expressing pCXneo retroviral vector either as pCX4neo/CARF-Myc or pCX4neo-CARF-GFP using FuGENE6 (Roche Applied Science). After 48 h, culture supernatants were collected, passed through 0.45-μm filters and used as viral stocks for infection. TIG-1 and MRC5 cells in 10-cm dishes were treated with 8 μg/ml polybrene at 37 °C for 1 h, following which cells were infected with 1 ml of filtered viral stock for 1 h, then 2 ml of Dulbecco's modified Eagle's medium was added, and the plates were incubated at 37 °C for another 48 h. Cells were selected in medium containing G418 (200 μg/ml) until stable cell lines were obtained. The expression of CARF was examined by Western blotting and immunostaining using anti-Myc or anti-GFP antibody as indicated. For growth rate analysis, 4 × 104 cells were seeded in 35-mm dish in duplicates. The cells were trypsinized and counted everyday for next 5 days. For induction of oncogene-induced SIPS, U2OS cells were transfected with expression plasmids encoding either the wild-type Ras (Wt Ras) or mutant oncogenic Ras (Mut Ras, G12V). Cells were selected in medium supplemented with G418 (500 μg/ml) for 15 days and were then examined for Ras and CARF levels by Western blotting as described below. CARF-compromised cells were generated by small interference RNA (siRNA) treatment. CARF-targeting 21-nucleotide RNAs were chemically synthesized using Expedite RNA phosphoramidites and thymidine phosphoramidite. Synthetic oligonucleotides were deprotected and gel-purified. Sequences of two control and two target oligos for CARF were 5′-AAGACCGAGUCCAUGAGGCUT-3′, 5′-GCCUCAUGGACUCGGUCUUUT-3′ and 5′-CGGAGUACCUGAGCCAGAAUT-3′, 5′-UUCUGGCUCAGGUACUCCGUT-3′, respectively. For annealing of siRNAs, 20 mm of two control or target single strands were incubated in annealing buffer (100 mm potassium acetate, 30 mm HEPES-KOH at pH 7.4, 2 mm magnesium acetate) for 1 min at 90 °C followed by 1 h at 37 °C. Transfections of siRNA duplexes were carried out using Oligofectamine reagent (Invitrogen). Typically, 1–5 μl of the 20 mm duplexes were used per 12-well dish and were assayed after 24–48 h by immunostaining and Western blotting with anti-CARF antibody as described below. Western Blotting—Cells treated with CARF and control siRNAs were harvested at 72-h post-transfection by resuspending cell pellets with lysis buffer containing 50 mm HEPES pH 7.5, 150 mm NaCl, 100 mm NaF, 1 mm phenylmethylsulfonyl fluoride, 0.5% Triton X-100, 0.5% Nonidet P-40, 1 mm dithiothreitol, 10% glycerol, and supplemented with a protease inhibitor mixture (Roche). The whole cell lysate was centrifuged at 13,000 rpm for 10 min at 4 °C to remove cell debris. The protein concentrations were determined by the Bradford protein assay following the manufacturer's instructions. Lysates containing 20–30 μg of protein were boiled in sodium dodecyl sulfate (SDS) sample buffer for 5 min, subjected to SDS-polyacrylamide gel electrophoresis under reducing conditions and then transferred onto Immobilon-P membranes (Millipore) using a semi-dry transfer apparatus (ATTO, Japan). After washing with TBS-T, the membrane was incubated with horseradish peroxidase-conjugated secondary antibody (goat anti-mouse or anti-rabbit from Santa Cruz Biotechnology) for 30 min. The membrane was washed three times in TBS-T and once in TBS, then subjected to enhanced chemiluminescence (ECL)-mediated visualization (Amersham Biosciences) using Lumino Image Analyzer equipped with CCD camera (LAS3000-mini, Fuji Film). Various antibodies used were anti-CARF (Fl-A10) (16Hasan M.K. Yaguchi T. Sugihara T. Kumar P.K. Taira K. Reddel R.R. Kaul S.C. Wadhwa R. J. Biol. Chem. 2002; 277: 37765-37770Abstract Full Text Full Text PDF PubMed Scopus (60) Google Scholar), anti-HDM2 (Santa Cruz Biotechnology, SMP-14), anti-p21WAF1 (Santa Cruz Biotechnology, C-19), anti-p53 (Santa Cruz Biotechnology, DO-1), anti-caspase-8 (BD-Pharmingen), anti-caspase-3 (Santa Cruz Biotechnology, H-277), anti-caspase-7 (Santa Cruz Biotechnology, C-18,), anti-caspase-9 (Santa Cruz Biotechnology, H-83), anti-Ras (Cell Signaling, Ab-3965,) anti-p16INK4A (Santa Cruz Biotechnology, Ab F-12), anti-pRB (Cell signaling, Ab4H-1), anti-Myc (Santa Cruz Biotechnology), and anti-actin antibody (Chemicon). Fluorescence and Confocal Microscopy—Fluorescence and laser confocal microscopy were used to observe cell phenotypes, cell cycle stages, and immunofluorescence. Cells grown on coverslips were fixed in 4% formaldehyde, permeabilized with 0.2% Triton X-100 and blocked with 5% bovine serum albumin in PBS. Cells were probed with primary antibodies against β-tubulin (monoclonal, Sigma), CARF (FL-A10, rabbit polyclonal), and phospho-H3 (monoclonal, Santa Cruz Biotechnology). Staining was visualized by Alexa 488 (mouse)- or Alexa 594 (rabbit)-conjugated secondary antibodies. Cells were also stained for nucleus with Hoechst dye (H-33258, Sigma) for 5 min and then mounted using FA mounting fluid (Difco). Images were taken using an Olympus (IX7151F-2, Japan) microscope equipped with confocal scanner unit (CSU-20, Yokogawa Inc., Japan) and EMCCD camera (Andor, UK), operating with the 488 nm (Argon), 351 nm and 364 nm (Argon and UV) laser, and a Carl Zeiss Axiovert microscope attached with Photometrics Synsys monochrome CCD. Senescence-associated β-Gal Assay—Senescent cells were detected using the standard protocol for senescence associated β-gal staining assay. In brief, cells were washed with PBS, fixed with 2% formaldehyde/0.2% glutaraldehyde in PBS for 10 min, washed again with PBS, followed by overnight incubation in staining solution (citric acid/phosphate buffer pH 6.0, 5 mm K3Fe (CN)6, 5 mm K4Fe(CN)6, 2 mm MgCl2, 150 mm NaCl, supplemented with 1 mg/ml of X-gal) at 37 °C. Stained cells were observed under the microscope and photodocumented with a NIKON camera. BrdU Incorporation Assay—TIG-1 cells were transfected with pEGFPN1 (Clontech) and pEGFPN1-CARF plasmids. After 48 h of transfection, 10 ml of BrdU labeling reagent (Amersham Biosciences) was added per ml of culture medium for 4 h. Cells were fixed and immunostained with anti-BrdU antibody following manufacturer's protocol. BrdU was visualized with Alexa 594-conjugated secondary antibody. About 400 GFP-positive cells were counted for BrdU incorporation in both CARF and vector-transfected culture. Apoptosis Assay—Cells grown on coverslips in 12-well plates were transfected with CARF and control siRNA for 72 h, then subjected to TUNEL assay (Promega), following the manufacturer's instructions provided with the kit. In addition, to verify apoptosis, cells were stained with Hoechst dye (333242) to determine the nuclear condensation and fragmentation. Live Cell Imaging—Cells were grown in glass bottom dish and transfected with CARF and control siRNA as described above. Between 48–60-h post-transfection, live cell microscopy was performed with a heated (37 °C) objective and stage incubator (Tokai Hit) using a laser spinning disc confocal microscope (Yokogawa electric Corp.) equipped with EMCCD camera (Andor, UK). Multicolor live cell imaging system was performed as previously described in detail (16Hasan M.K. Yaguchi T. Sugihara T. Kumar P.K. Taira K. Reddel R.R. Kaul S.C. Wadhwa R. J. Biol. Chem. 2002; 277: 37765-37770Abstract Full Text Full Text PDF PubMed Scopus (60) Google Scholar). Images were recorded at intervals of 3 min and each z-series typically contained 5–10 slices of up to 20 μmin thickness. Image stacks were converted to maximum intensity projections using Lumina Vision software (Mitani Corp., Fukui, Japan). Overexpression of CARF Caused Premature Senescence of Human Fibroblasts—To resolve the function of CARF, it was overexpressed in human fetal lung fibroblasts (MRC5) that harbor a complete set of its downstream effector components (p53, HDM2 and p21WAF1). MRC5 cells were infected with CARF-Myc expressing retroviral vector at PD 30; the expression was confirmed by Western blotting and immunostaining with anti-Myc antibody for more than three subsequent population doublings (Fig. 1, A and B; data not shown). Control and CARF-overexpressing cells were serially passaged. Whereas CARF-overexpressing cells showed senescence at PD 40, the control cells senesced at about 60 PD. We examined senescence specific markers in control and CARF-overexpressing cells and found that consistent with senescence-like morphology and loss of proliferation, the CARF-overexpressing cells showed autofluorescence, senescence-specific β-gal staining and enhanced levels of p53 protein and its downstream effector, p21WAF1 (Fig. 1C). Similar results were obtained when CARF was overexpressed in human fetal skin fibroblasts (TIG-1) using GFP-CARF fusion protein (Fig. 1, A and D). CARF-overexpressing TIG-1 cells showed premature senescence (45 PD in contrast to 67 PD in control cells), also signified by altered cell morphology (enlarged, flattened, multinucleated cells and lack of spiral arrangement), enhanced β-gal staining, autofluorescence, and inhibition of DNA synthesis (Fig. 1D and data not shown) and slower growth rate as compared with the vector-infected control cells (Fig. 1E). Of note, CARF overexpression in cells that lack p53, MDM2 and p21WAF1, did not induce senescence suggesting that the effect is predominantly mediated by p53 pathway. This was consistent with our earlier data in which overexpression of CARF induced strong growth arrest in U2OS and HCT116 (wild-type p53 function) but was not effective in Saos-2 that lack functional p53 (10Hasan M.K. Yaguchi T. Minoda Y. Hirano T. Taira K. Wadhwa R. Kaul S.C. Biochem. J. 2004; 380: 605-610Crossref PubMed Scopus (35) Google Scholar). CARF Is Up-regulated during Replicative and Stress-induced Senescence—Induction of premature senescence with overexpression of CARF led us to examine its role during replicative senescence of normal cells. We found that CARF expression was distinctly increased at later passages of human normal cells and most interestingly, it correlated with enhanced levels of p21WAF1 and reduction in HDM2 (Fig. 2A). These data were consistent with the previously demonstrated functions of CARF as (i) collaborator of ARF (16Hasan M.K. Yaguchi T. Sugihara T. Kumar P.K. Taira K. Reddel R.R. Kaul S.C. Wadhwa R. J. Biol. Chem. 2002; 277: 37765-37770Abstract Full Text Full Text PDF PubMed Scopus (60) Google Scholar) and p53 (10Hasan M.K. Yaguchi T. Minoda Y. Hirano T. Taira K. Wadhwa R. Kaul S.C. Biochem. J. 2004; 380: 605-610Crossref PubMed Scopus (35) Google Scholar) and (ii) transcriptional repressor of HDM2 (11Hasan M.K. Yaguchi T. Harada J.I. Hirano T. Wadhwa R. Kaul S.C. Int. J. Oncol. 2008; 32: 663-671PubMed Google Scholar). Of note, we found a strong correlation between up-regulation of CARF with increase in p53 and p21WAF1 (Fig. 2, B and C). Furthermore, it also correlated with presence of endogenous β-gal activity in senescent fibroblasts (Fig. 2D). In senescent cultures, more than 75% cells were enriched with CARF and p21WAF1 expression in concert. Endogenous β-gal staining revealed equivalent percentage of positive cells (Fig. 2D). We next investigated if CARF was also involved in stress-induced premature senescence (SIPS) of human cells. As shown in Fig. 3, exposure of TIG-1 (normal human fibroblasts) and U2OS (osteosarcoma) cells to an oxidative stress agent (H2O2) caused senescence as detected by β-gal staining (Fig. 3A). Significantly, CARF was up-regulated in both the cell types, and paralleled the increase in p53 and p21WAF1 proteins (Fig. 3, B and C). Of note, premature senescence induced by oncogenic ras also showed clear up-regulation of CARF (Fig. 3D).FIGURE 3CARF is up-regulated in SIPS. A, induction of SIPS by oxidative stress resulted in appearance of senescence-associated β-gal. B–C, up-regulation of CARF, p53 and p21WAF1 as detected by Western blotting (B) and immunostaining (C). D, induction of SIPS by mutant Ras (G12V) also involved increase in CARF level.View Large Image Figure ViewerDownload Hi-res image Download (PPT) CARF-compromised Cells Undergo Apoptosis—Based on the above data, on the role of CARF in cellular senescence, we predicted that CARF-compromised cells might be able to escape senescence and progress to immortalization. We tested this by employing CARF siRNA in normal (TIG-1 and MRC5) cells (Fig. 4A). Contrary to our prediction, we found that CARF siRNA caused cell death resembling apoptosis. Similar results were obtained in cancer (HeLa and U2OS) cells (Fig. 4A), suggesting that CARF may have some essential function in both normal and cancer cells. In CARF-compromised cells, CARF siRNA (which caused 60–80% reduction in CARF expression) (Fig. 4B and data not shown) not only reduced the levels of p53 and p21WAF1 (assessed as transcriptional activation function of p53) (Fig. 4, B and C), but also caused induction of cleavage of caspase-8, caspase-3, caspase-7, and caspase-9 (Fig. 4, B–D). These data firmly suggested that the CARF-compromised cells undergo cell death by caspase-mediated apoptosis. Furthermore caspase inhibitor z-VAD-fmk caused inhibition of cell death caused by CARF knockdown (Fig. 4E). These data confirmed the role of CARF in apoptosis that was mediated by caspase pathways. We also tested if CARF was suppressed during drug-induced apoptosis by using staurosporine as a model reagent. As shown in Fig. 4F, the expression level of CARF was found to be decreased during staurosporine-induced apoptosis, also marked by an increase in amount of cleaved caspase-8. To investigate the role of CARF in both growth arrest and apoptosis, we next used a doxorubicin model of cell death. Low doses of doxorubicin are known to cause growth arrest of cells that resembles senescence, and high doses cause apoptosis (Fig. 4G). Of note, consistent with the above data on the induction of senescence with overexpression of CARF, its expression was increased with low doses of doxorubicin (0.25–0.50 μg/ml) in both U2OS and HeLa cells (Fig. 4G). An increase in the level of CARF expression was paralleled with increase in p53 and p21WAF1 proteins. High doses of doxorubicin (1–3 μg/ml) that resulted in cell death (Fig. 4G), caused reduction in CARF, p53 level and activity (observed by p21WAF1 level), and induced cleavage of caspase-8 (Fig. 4G), signifying apoptosis. Similar results were obtained with doxorubicin, etoposide, and camptothecin treatments in U2OS, HeLa, and HCT116 cells (data not shown), suggesting that the involvement of CARF in senescence and apoptosis is not a cell type or drug-specific response. In view of the role of CARF both in growth arrest and apoptosis as described above, we also performed reconstitution of CARF in CARF-compromised cells by Zn-inducible CARF expression system (11Hasan M.K. Yaguchi T. Harada J.I. Hirano T. Wadhwa R. Kaul S.C. Int. J. Oncol. 2008; 32: 663-671PubMed Google Scholar, 16Hasan M.K. Yaguchi T. Sugihara T. Kumar P.K. Taira K. Reddel R.R. Kaul S.C. Wadhwa R. J. Biol. Chem. 2002; 277: 37765-37770Abstract Full Text Full Text PDF PubMed Scopus (60) Google Scholar). CARF expression was induced at 3-h post-transfection of CARF-siRNA. The results revealed that (i) CARF siRNA was specific and highly efficient; whereas CARF was strongly induced by ZnSO4 in control-siRNA-transfected cells, the presence of CARF-siRNA strongly compromised the reconstitution, (ii) consistent with the overexpression of CARF and p21WAF1, the control-siRNA transfected cells showed strong growth arrest, and (iii) CARF-siRNA compromised the CARF and p21WAF1 levels and resulted in decline in viability (Fig. 4H) that represented combined effect of growth arrest and apoptosis mediated by CARF overexpression and silencing, respectively as also supported by the data in Figs. 2A, 3, A–D, and 4, A–G). Similar effects of CARF-siRNA and reconstitution of CARF expression were recorded by using HDM2 reporter assay (11Hasan M.K. Yaguchi T. Harada J.I. Hirano T. Wadhwa R. Kaul S.C. Int. J. Oncol. 2008; 32: 663-671PubMed Google Scholar). Whereas CARF overexpression caused decline in HDM-2, increase in p53 and growth arrest in U2OS cells, CARF siRNA abrogated these effects (11Hasan M.K. Yaguchi T. Harada J.I. Hirano T. Wadhwa R. Kaul S.C. Int. J. Oncol. 2008; 32: 663-671PubMed Google Scholar, 16Hasan M.K. Yaguchi T. Sugihara T. Kumar P.K. Taira K. Reddel R.R. Kaul S.C. Wadhwa R. J. Biol. Chem. 2002; 277: 37765-37770Abstract Full Text Full Text PDF PubMed Scopus (60) Google Scholar). To get further insights into the mechanism of CARF-silencing induced cell death, we observed that a high number of CARF-compromised cells were TUNEL positive and had condensed chromatin (Hoechst staining), suggesting that CARF silencing caused apoptosis and abnormal cell division (Fig. 5A). Consistent with the presence of condensed chromatin, CARF-suppressed cells were enriched with phosphorylated H3 histone (Fig. 5B), an early marker of mitosis (18Sauve D.M. Anderson H.J. Ray J.M. James W.M. Roberge M. J. Cell Biol. 1999; 145: 225-235Crossref PubMed Scopus (115) Google Scholar). The result indicated that the mitotic progression was inhibited in CARF knockdown cells and that may have been arrested in pro-metaphase stage. Cell cycle analysis of control and CARF siRNA transfected also revealed a 2.6-fold increase in cells at G2/M phase and decrease in cells at G1 suggesting CARF is required for mitotic progression (Fig. 5C). We examined γ-tubulin immunostaining of spindle fibers in CARF-compromised cells and found high proportion of multi-polar, aneuploid, and enlarged cells (Fig. 5, D and E). Time-Lapse Sequence of G2/M Progression in CARF-compromised (with siRNA) Cells—Based on the above data, we performed live cell imaging (time-lapse microscopy) to observe cell division in control and CARF-siRNA-transfected cells as described under “Materials and Methods.” As shown in Fig. 6A, mitotic cycle was visually determined by rounding of the parent cells with condensed chromatin and separation into two daughter cells by cytokinesis. In control cells, mitosis completed in ∼40 min, while in CARF-siRNA-treated cells, although many cells rounded up as in normal mitosis, they did not complete cell division even over a period of 8 h. Instead, these cells were triggered to undergo apoptosis, as shown by their typical blebbing phenotype (Fig. 6, A and B; supplemental Movies S1A and S1B). Similar results were obtained in U2OS, HeLa, and MDA-MB-435 cells. To further prove this phenomenon, we used the multicolor MDA-MB-435 Auro/imp/H3 cell line stably expressing GFP-Aurora A kinase, DsRed-D importin α2 (DsRed-importin), and CFP-histone H3, simultaneously, as markers for the centrosomes/mitotic spindles, nuclear membrane and nucleus/chromosomes, respectively (17Sugimoto K. Urano T. Zushi H. Inoue K. Tasaka H. Tachibana M. Dotsu M. Cell Struct. Funct. 2002; 27: 457-467Crossref PubMed Scopus (48) Google Scholar), and performed live cell imaging. As shown in Fig. 7A, untransfected and control siRNA-transfected cells clearly showed the different stages of mitosis, including disappearance of nuclear envelope (red), condensation of chromatin (blue), appearance of spindle poles (green), aligning of chromosomes on metaphase plates, separation of two chromosome sets and progression to anaphase, resulting in two daughter nuclei after the disappearance of the centrosome and reformation of the nuclear envelope (Fig. 7A, supplemental Movie S2). In sharp contrast, CARF-compromised cells showed very faint signal for the centrosome, extensive chromatin condensation ultimately forming a single large structure and an accumulation of importin in the nucleus (Fig. 7B and supplemental Movie S3). Taken together, these data demonstrated that CARF is essential for normal progression of cell division; its absence causes inadequate centrosome formation, excessive chromatin condensation leading to aneuploidy and apoptosis, as evidenced by data in Figs. 6 and 7.FIGURE 7Time lapse examination of mitosis in CARF-compromised multi-label MDA-MB435 cells. A, untransfected cells underwent normal mitosis. (a) Merged image of triply labeled cells, CFP-histone H3 (blue, b), DsRed-importin α (red, c), and GFP-Aurora A (green, d) are shown. Mitotic cell (marked by chromatin condensation and disappearance of nuclear envelope indicated by white arrowheads in b and c, respectively) are shown. At 3 min, appearance of two spindle poles (centrosomes) (black arrowheads in d) was marked. Chromosomes aligned to the cell equator and formed the metaphase plate (24 min). Cell entered anaphase at 36 min (shown by white arrows in b) followed by formation of two daughter nuclei with reformation of nuclear envelope that gradually expanded along with the decondensation of chromatin, disappearance of centrosomes (42–123 min) and exit of mitosis (arrows in d). See also supplemental Movies S2, A–D. B, in CARF-compromised cells, centrosome formation was diminished (12 min, black arrowheads in d indicate very faint centrosomes), nucleus slightly contracted (24–33 min) be" @default.
• W2010481034 created "2016-06-24" @default.
• W2010481034 creator A5006335830 @default.
• W2010481034 creator A5020220178 @default.
• W2010481034 creator A5053340529 @default.
• W2010481034 creator A5053529984 @default.
• W2010481034 creator A5057392976 @default.
• W2010481034 creator A5059888683 @default.
• W2010481034 creator A5062012456 @default.
• W2010481034 creator A5086434812 @default.
• W2010481034 creator A5087564630 @default.
• W2010481034 date "2009-01-01" @default.
• W2010481034 modified "2023-10-16" @default.
• W2010481034 title "CARF Is a Vital Dual Regulator of Cellular Senescence and Apoptosis" @default.
• W2010481034 cites W1650797637 @default.
• W2010481034 cites W1966380833 @default.
• W2010481034 cites W1967232610 @default.
• W2010481034 cites W1983751803 @default.
• W2010481034 cites W1984185924 @default.
• W2010481034 cites W1987213387 @default.
• W2010481034 cites W1990572469 @default.
• W2010481034 cites W1991324349 @default.
• W2010481034 cites W1992934869 @default.
• W2010481034 cites W2004273407 @default.
• W2010481034 cites W2011111850 @default.
• W2010481034 cites W2027700437 @default.
• W2010481034 cites W2034980302 @default.
• W2010481034 cites W2035188342 @default.
• W2010481034 cites W2036598177 @default.
• W2010481034 cites W2040616051 @default.
• W2010481034 cites W2041156660 @default.
• W2010481034 cites W20768369 @default.
• W2010481034 cites W2086333179 @default.
• W2010481034 cites W2088926897 @default.
• W2010481034 cites W2093603211 @default.
• W2010481034 cites W2093837468 @default.
• W2010481034 cites W2095916340 @default.
• W2010481034 cites W2106022030 @default.
• W2010481034 cites W2117039207 @default.
• W2010481034 cites W2120598012 @default.
• W2010481034 cites W2124023605 @default.
• W2010481034 cites W2138936179 @default.
• W2010481034 cites W2143544816 @default.
• W2010481034 cites W2154799239 @default.
• W2010481034 cites W2154855968 @default.
• W2010481034 cites W2160178368 @default.
• W2010481034 cites W2614825120 @default.
• W2010481034 cites W2917550355 @default.
• W2010481034 doi "https://doi.org/10.1074/jbc.m805778200" @default.
• W2010481034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19001376" @default.
• W2010481034 hasPublicationYear "2009" @default.
• W2010481034 type Work @default.
• W2010481034 sameAs 2010481034 @default.
• W2010481034 citedByCount "39" @default.
• W2010481034 countsByYear W20104810342012 @default.
• W2010481034 countsByYear W20104810342013 @default.
• W2010481034 countsByYear W20104810342014 @default.
• W2010481034 countsByYear W20104810342015 @default.
• W2010481034 countsByYear W20104810342016 @default.
• W2010481034 countsByYear W20104810342017 @default.
• W2010481034 countsByYear W20104810342018 @default.
• W2010481034 countsByYear W20104810342019 @default.
• W2010481034 countsByYear W20104810342020 @default.
• W2010481034 countsByYear W20104810342021 @default.
• W2010481034 countsByYear W20104810342022 @default.
• W2010481034 countsByYear W20104810342023 @default.
• W2010481034 crossrefType "journal-article" @default.
• W2010481034 hasAuthorship W2010481034A5006335830 @default.
• W2010481034 hasAuthorship W2010481034A5020220178 @default.
• W2010481034 hasAuthorship W2010481034A5053340529 @default.
• W2010481034 hasAuthorship W2010481034A5053529984 @default.
• W2010481034 hasAuthorship W2010481034A5057392976 @default.
• W2010481034 hasAuthorship W2010481034A5059888683 @default.
• W2010481034 hasAuthorship W2010481034A5062012456 @default.
• W2010481034 hasAuthorship W2010481034A5086434812 @default.
• W2010481034 hasAuthorship W2010481034A5087564630 @default.
• W2010481034 hasBestOaLocation W20104810341 @default.
• W2010481034 hasConcept C104317684 @default.
• W2010481034 hasConcept C124952713 @default.
• W2010481034 hasConcept C127716648 @default.
• W2010481034 hasConcept C142362112 @default.
• W2010481034 hasConcept C185592680 @default.
• W2010481034 hasConcept C190283241 @default.
• W2010481034 hasConcept C21951064 @default.
• W2010481034 hasConcept C2779523775 @default.
• W2010481034 hasConcept C2780980858 @default.
• W2010481034 hasConcept C3019440502 @default.
• W2010481034 hasConcept C522857546 @default.
• W2010481034 hasConcept C55493867 @default.
• W2010481034 hasConcept C6929976 @default.
• W2010481034 hasConcept C86803240 @default.
• W2010481034 hasConcept C95444343 @default.
• W2010481034 hasConceptScore W2010481034C104317684 @default.
• W2010481034 hasConceptScore W2010481034C124952713 @default.
• W2010481034 hasConceptScore W2010481034C127716648 @default.
• W2010481034 hasConceptScore W2010481034C142362112 @default.
• W2010481034 hasConceptScore W2010481034C185592680 @default.
• W2010481034 hasConceptScore W2010481034C190283241 @default.

• next